Risk factors for severe and critically ill COVID‐19 patients: a review
Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
M Apicella, MC Campopiano, M Mantuano… - The lancet Diabetes & …, 2020 - thelancet.com
Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …
Biomarkers associated with COVID-19 disease progression
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19
Statins are lipid-lowering therapeutics with favorable anti-inflammatory profiles and have
been proposed as an adjunct therapy for COVID-19. However, statins may increase the risk …
been proposed as an adjunct therapy for COVID-19. However, statins may increase the risk …
Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2
F Salamanna, M Maglio, MP Landini, M Fini - Frontiers in medicine, 2020 - frontiersin.org
The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …
COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge
J Baj, H Karakuła-Juchnowicz, G Teresiński… - Journal of clinical …, 2020 - mdpi.com
Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …
Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
COVID-19 and sex differences: mechanisms and biomarkers
T Haitao, JV Vermunt, J Abeykoon, R Ghamrawi… - Mayo Clinic …, 2020 - Elsevier
Men are consistently overrepresented in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection, and coronavirus disease 2019 (COVID-19) severe outcomes …
(SARS-CoV-2) infection, and coronavirus disease 2019 (COVID-19) severe outcomes …